Fig. 1: Steroid impact on progression-free survival.

Kaplan-Meier plot comparing progression-free survival between patients exposed (blue curve) and unexposed (red curve) to corticosteroids within 30 days post-administration of CAR T-cell therapy for relapsed/refractory multiple myeloma.